← Back to Search

Dopamine Antagonist

Domperidone for Delayed Gastric Emptying

N/A
Waitlist Available
Led By Mayra Sanchez, MD
Research Sponsored by Jill Deutsch
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 years
Awards & highlights
No Placebo-Only Group

Summary

To prescribe oral domperidone for patients with upper GI symptoms who have failed or suffered adverse effects from standard medical therapy.

Eligible Conditions
  • Delayed Gastric Emptying
  • Gastroparesis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reduction of upper GI symptoms

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients receiving DomperidoneExperimental Treatment1 Intervention
Patients with upper GI symptoms who have failed or suffered adverse effects from standard medical therapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Domperidone
2011
Completed Phase 4
~401020

Find a Location

Who is running the clinical trial?

Jill DeutschLead Sponsor
Yale UniversityLead Sponsor
1,919 Previous Clinical Trials
3,040,355 Total Patients Enrolled
Mayra Sanchez, MDPrincipal InvestigatorYale University
~233 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top